Dr Mark Donoghoe

Dr Mark Donoghoe

Senior Research Fellow

B Sc (Adv) (Hons), PhD

Medicine & Health
Faculty Office
Phone
+61-2-9065 6602
Location
Wallace Wurth Building (C27), Level 5 Kensington UNSW Sydney NSW 2052
  • Journal articles | 2024
    Cayrol J; Wakefield CE; Ilbawi A; Donoghoe M; Hoffman R; Echodu M; Schilstra C; Ortiz R; Wiener L, 2024, 'The lived experience of people affected by cancer: A global cross-sectional survey protocol', PLoS ONE, 19, http://dx.doi.org/10.1371/journal.pone.0294492
    Journal articles | 2023
    Body A; Donoghoe MW; Ahern ES; Lal L; Downie P; Leahy MF; Fuentes-Bolanos N; Anazodo A; Padhye B; Hamad N; Wakefield CE; Segelov E, 2023, '2106P Safety and patient reported outcomes of SARS-CoV-2 vaccination in patients with cancer', Annals of Oncology, 34, pp. S1104 - S1104, http://dx.doi.org/10.1016/j.annonc.2023.09.888
    Journal articles | 2023
    Craig AT; Leong RNF; Donoghoe MW; Muscatello D; Mojica VJC; Octavo CJM, 2023, 'Comparison of statistical methods for the early detection of disease outbreaks in small population settings', IJID Regions, 8, pp. 157 - 163, http://dx.doi.org/10.1016/j.ijregi.2023.08.007
    Journal articles | 2023
    Gereis JM; Hetherington K; Robertson EG; Daly R; Donoghoe MW; Ziegler DS; Marshall GM; Lau LMS; Marron JM; Wakefield CE, 2023, 'Parents’ and adolescents’ perspectives and understanding of information about childhood cancer precision medicine', Cancer, 129, pp. 3645 - 3655, http://dx.doi.org/10.1002/cncr.34914
    Journal articles | 2023
    LEUNG ONG K; O'CONNELL RL; JANUSZEWSKI AS; DONOGHOE MW; GEBSKI VAL; SULLIVAN D; ANN RYE K; SCOTT RS; BEST JD; TASKINEN M-R; SIMES RJ; JENKINS A; KEECH AC, 2023, '1350-P: Risk Models for the Development of Cardiovascular and Microvascular Events in Adults with Type 2 Diabetes in the FIELD Study', Diabetes, 72, http://dx.doi.org/10.2337/db23-1350-p
    Journal articles | 2023
    McGill BC; Wakefield CE; Tucker KM; Daly RA; Donoghoe MW; Vetsch J; Warby M; Fuentes-Bolanos NA; Barlow-Stewart K; Kirk J; Courtney E; O’Brien TA; Marshall GM; Pinese M; Cowley MJ; Tyrrell V; Deyell RJ; Ziegler DS; Hetherington K, 2023, 'Parents’ expectations, preferences, and recall of germline findings in a childhood cancer precision medicine trial', Cancer, 129, pp. 3620 - 3632, http://dx.doi.org/10.1002/cncr.34917
    Journal articles | 2023
    Nagabushan S; Hamayun M; Fardell JE; Donoghoe M; Bland E; Bye A; Jacobson E; Manoharan N; Ziegler DS; McLoone JK; Johnson AM; Cohn RJ, 2023, 'LGG-11. COGNITIVE, ACADEMIC, AND QUALITY OF LIFE OUTCOMES IN SURVIVORS OF PEDIATRIC LOW-GRADE GLIOMA: CHALLENGING THE ‘BENIGN TUMOR’ PERCEPTION', Neuro-Oncology, 25, pp. i57 - i58, http://dx.doi.org/10.1093/neuonc/noad073.221
    Journal articles | 2023
    Riepsamen AH; Donoghoe MW; Indran IR; Hechtman L; Robertson DM; Gilchrist RB; Ledger WL; Yong EL, 2023, 'Serum GDF9 and BMP15 as potential markers of ovarian function in women with and without polycystic ovary syndrome', Clinical Endocrinology, 98, pp. 567 - 577, http://dx.doi.org/10.1111/cen.14851
    Journal articles | 2023
    Shamsa A; Gilchrist RB; Robertson DM; Rodgers RJ; Donoghoe MW; Ledger WL; Abbott JA; Riepsamen AH, 2023, 'Oocyte-Secreted Serum Biomarkers GDF9 and BMP15 in Women with Endometriosis', Reproductive Sciences, 30, pp. 1521 - 1527, http://dx.doi.org/10.1007/s43032-022-01107-6
    Journal articles | 2023
    Spitzer H; Berry S; Donoghoe M; Pelkmans L; Theis FJ, 2023, 'Learning consistent subcellular landmarks to quantify changes in multiplexed protein maps', Nature Methods, 20, pp. 1058 - 1069, http://dx.doi.org/10.1038/s41592-023-01894-z
    Journal articles | 2023
    Wakefield CE; Hetherington K; Robertson EG; Donoghoe MW; Hunter JD; Vetsch J; Marron JM; Tucker KM; Marshall GM; Broom A; Haber M; Tyrrell V; Malkin D; Lau L; Mateos MK; O’Brien TA; Ziegler DS, 2023, 'Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectives', British Journal of Cancer, 129, pp. 1634 - 1644, http://dx.doi.org/10.1038/s41416-023-02429-1
    Journal articles | 2022
    Donoghoe MW; Marschner IC, 2022, 'Parameter expansion for fitting regression models with non-negativity constraints', Communications in Statistics: Simulation and Computation, http://dx.doi.org/10.1080/03610918.2022.2154791
    Journal articles | 2022
    Hetherington K; Wakefield CE; Kunalan KPK; Donoghoe MW; McGill BC; Fardell JE; Daly R; Deyell RJ; Ziegler DS, 2022, 'Quality of Life (QoL) of Children and Adolescents Participating in a Precision Medicine Trial for High-Risk Childhood Cancer', Cancers, 14, http://dx.doi.org/10.3390/cancers14215310
    Journal articles | 2022
    RIEPSAMEN AH; DONOGHOE MW; INDRAN IR; LIEN S; HECHTMAN L; ROBERTSON DM; GILCHRIST RB; YONG E-L; LEDGER WL, 2022, 'Serum GDF9 and BMP15 as Markers of Ovarian Function in Healthy Women and Women with Polycystic Ovary Syndrome', Fertility & Reproduction, 04, pp. 141 - 141, http://dx.doi.org/10.1142/s266131822274053x
    Journal articles | 2022
    Schilstra CE; McCleary K; Fardell JE; Donoghoe MW; McCormack E; Kotecha RS; Lourenco RDA; Ramachandran S; Cockcroft R; Conyers R; Cross S; Dalla-Pozza L; Downie P; Revesz T; Osborn M; Alvaro F; Wakefield CE; Marshall GM; Mateos MK; Trahair TN, 2022, 'Prospective longitudinal evaluation of treatment-related toxicity and health-related quality of life during the first year of treatment for pediatric acute lymphoblastic leukemia', BMC Cancer, 22, http://dx.doi.org/10.1186/s12885-022-10072-x
    Journal articles | 2021
    Hsu J; Sansom-Daly UM; Hetherington K; Ellis SJ; Donoghoe MW; Cohn RJ; Zentella-Tusie A; Wakefield CE, 2021, 'Health service and medication use of parents of childhood cancer survivors: a controlled comparison study', Acta Oncologica, 60, pp. 1325 - 1334, http://dx.doi.org/10.1080/0284186X.2021.1955968
    Journal articles | 2021
    Kamaladasa DS; Sansom-Daly UM; Hetherington K; McGill BC; Ellis SJ; Kelada L; Donoghoe MW; Evans H; Anazodo A; Patterson P; Cohn RJ; Wakefield CE, 2021, 'How Are Families Faring? Perceived Family Functioning among Adolescent and Young Adult Cancer Survivors in Comparison to Their Peers', Journal of Adolescent and Young Adult Oncology, 10, pp. 711 - 719, http://dx.doi.org/10.1089/jayao.2020.0215
    Journal articles | 2021
    Riepsamen AH; Donoghoe MW; Baerwald A; Pankhurst MW; Lien S; Chong YH; Robertson DM; Ledger WL; Gilchrist RB, 2021, 'Exploratory analysis of serum concentrations of oocyte biomarkers growth differentiation factor 9 and bone morphogenetic protein 15 in ovulatory women across the menstrual cycle', Fertility and Sterility, 116, pp. 546 - 557, http://dx.doi.org/10.1016/j.fertnstert.2021.02.001
    Journal articles | 2021
    Riepsamen AH; Donoghoe MW; Baerwald A; Pankhurst MW; Lien S; Chong YH; Robertson DM; Ledger WL; Gilchrist RB, 2021, 'Serum Concentrations of GDF9 and BMP15 Across the Menstrual Cycle', Journal of the Endocrine Society, 5, pp. A734 - A735, http://dx.doi.org/10.1210/jendso/bvab048.1494
    Journal articles | 2021
    Sansom‐daly UM; Wakefield CE; Ellis SJ; McGill BC; Donoghoe MW; Butow P; Bryant RA; Sawyer SM; Patterson P; Anazodo A; Plaster M; Thompson K; Holland L; Osborn M; Maguire F; O’dwyer C; Lourenco RDA; Cohn RJ, 2021, 'Online, group‐based psychological support for adolescent and young adult cancer survivors: Results from the recapture life randomized trial', Cancers, 13, http://dx.doi.org/10.3390/cancers13102460
    Journal articles | 2021
    Sansom‐daly UM; Wakefield CE; Signorelli C; Donoghoe MW; Anazodo A; Sawyer SM; Osborn M; Viney R; Daniell N; Faasse K; Cohn RJ, 2021, 'Patterns and predictors of healthcare use among adolescent and young adult cancer survivors versus a community comparison group', Cancers, 13, http://dx.doi.org/10.3390/cancers13215270
    Journal articles | 2021
    Wakefield CE; Sansom‐daly UM; McGill BC; Hetherington K; Ellis SJ; Robertson EG; Donoghoe MW; McCarthy M; Kelada L; Girgis A; King M; Grootenhuis M; Anazodo A; Patterson P; Lowe C; Dalla‐pozza L; Miles G; Cohn RJ, 2021, 'Providing psychological support to parents of childhood cancer survivors: ‘cascade’ intervention trial results and lessons for the future', Cancers, 13, http://dx.doi.org/10.3390/cancers13225597
    Journal articles | 2020
    Barbour AP; Samra JS; Haghighi KS; Donoghoe MW; Burge M; Harris MT; Chua YJ; Mitchell J; O’Rourke N; Chan H; Gebski VJ; Gananadha S; Croagh DG; Kench JG; Goldstein D; Barbour A; Goldstein D; Samra JS; Harris M; Chua YJ; Yip S; Simes J; Hicks R; Coates A; Gurney H; Do V; Marschner I; Mitchell J; Donoghoe M; Goldstone S; Yip S; Chua YJ; Pavlakis N; Goldstein D; Aghmesheh M; Joubert W; Grimes D; Harris M; Burge M; Bagia S; Jaber M; Gananadha S; Bryant R; Nathanson L; Cavallucci D; Barbour A; Fawcett J; O’Rourke T; Croagh D; Jones R, 2020, 'The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer', Annals of Surgical Oncology, 27, pp. 2506 - 2515, http://dx.doi.org/10.1245/s10434-020-08205-2
    Journal articles | 2020
    Barlow EL; Lambie N; Donoghoe MW; Naing Z; Hacker NF, 2020, 'The Clinical Relevance of p16 and p53 Status in Patients with Squamous Cell Carcinoma of the Vulva', Journal of Oncology, 2020, http://dx.doi.org/10.1155/2020/3739075
    Journal articles | 2019
    Kelada L; Wakefield CE; Heathcote LC; Jaaniste T; Signorelli C; Fardell JE; Donoghoe M; McCarthy MC; Gabriel M; Cohn RJ, 2019, 'Perceived cancer-related pain and fatigue, information needs, and fear of cancer recurrence among adult survivors of childhood cancer', Patient Education and Counseling, 102, pp. 2270 - 2278, http://dx.doi.org/10.1016/j.pec.2019.06.022
    Journal articles | 2019
    Riepsamen AH; Chan K; Lien S; Sweeten P; Donoghoe MW; Walker G; Fraison EHJ; Stocker WA; Walton KL; Harrison CA; Ledger WL; Robertson DM; Gilchrist RB, 2019, 'Serum Concentrations of Oocyte-Secreted Factors BMP15 and GDF9 during IVF and in Women with Reproductive Pathologies', Endocrinology, 160, pp. 2298 - 2313, http://dx.doi.org/10.1210/en.2019-00264
    Journal articles | 2019
    Robertson EG; Wakefield CE; Cohn RJ; Battisti RA; Donoghoe MW; Ziegler DS; Fardell JE; Mitchell R; O'Brien TA, 2019, 'Piloting a parent and patient decision aid to support clinical trial decision making in childhood cancer', Psycho-Oncology, 28, pp. 1520 - 1529, http://dx.doi.org/10.1002/pon.5109
    Journal articles | 2019
    Stenson BJ; Donoghoe M; Brocklehurst P; Davis PG; Juszczak E; Marschner IC; Simes J; Tarnow-Mordi WO, 2019, 'Pulse Oximeter Saturation Targeting and Oximeter Changes in the Benefits of Oxygen Saturation Targeting (BOOST)-II Australia and BOOST-II UK Oxygen Trials', Journal of Pediatrics, 204, pp. 301 - 304.e2, http://dx.doi.org/10.1016/j.jpeds.2018.08.033
    Journal articles | 2018
    Craig AT; Joshua CA; Sio AR; Donoghoe M; Betz-Stablein B; Bainivalu N; Dalipanda T; Kaldor J; Rosewell AE; Schierhout G, 2018, 'Epidemic surveillance in a low resource setting: Lessons from an evaluation of the Solomon Islands syndromic surveillance system, 2017', BMC Public Health, 18, http://dx.doi.org/10.1186/s12889-018-6295-7
    Journal articles | 2018
    Donoghoe MW; Marschner IC, 2018, 'Logbin: An R package for relative risk regression using the log-binomial model', Journal of Statistical Software, 86, http://dx.doi.org/10.18637/jss.v086.i09
    Journal articles | 2017
    Donoghoe MW; Gebski V, 2017, 'The importance of censoring in competing risks analysis of the subdistribution hazard', BMC Medical Research Methodology, 17, http://dx.doi.org/10.1186/s12874-017-0327-3
    Journal articles | 2017
    Mitchell P; Siva S; Kok PS; O'Byrne K; Yeung A; Livingstone A; Donoghoe M; Yip S; Stockler MR, 2017, 'NIVORAD: A randomised phase 2 trial of nivolumab and stereotactic ablative body radiotherapy in advanced non-small cell lung cancer, progressing after first or second line chemotherapy.', Journal of Clinical Oncology, 35, pp. TPS9097 - TPS9097, http://dx.doi.org/10.1200/jco.2017.35.15_suppl.tps9097
    Journal articles | 2017
    Nowak A; Kok P-S; Livingstone A; Lesterhuis WJ; Yip S; Donoghoe M; Lam W-S; Stockler M, 2017, 'P2.06-025 DREAM - A Phase 2 Trial of DuRvalumab with First Line chEmotherApy in Mesothelioma with a Safety Run In', Journal of Thoracic Oncology, 12, pp. S1086 - S1087, http://dx.doi.org/10.1016/j.jtho.2016.11.1518
    Journal articles | 2016
    Barbour A; O'Rourke N; Chan H; Chua YJ; Kench J; Hicks RJ; Samra JS; Pavlakis N; Haghighi KS; Yip S; Donoghoe M; Friend C; Burge ME; Fawcett J; Harris M; Aghmesheh M; Joubert WL; Gebski V; Simes J; Goldstein D, 2016, 'Initial survival outcomes for the AGITG GAP study - a phase II study of perioperative nab-paclitaxel and gemcitabine for resectable pancreatic ductal adenocarcinoma (PDAC)', JOURNAL OF CLINICAL ONCOLOGY, 34, http://dx.doi.org/10.1200/JCO.2016.34.15_suppl.4105
    Journal articles | 2016
    Donoghoe MW; Marschner IC, 2016, 'Estimation of adjusted rate differences using additive negative binomial regression', Statistics in Medicine, 35, pp. 3166 - 3178, http://dx.doi.org/10.1002/sim.6960
    Journal articles | 2016
    Tarnow-Mordi W; Stenson B; Kirby A; Juszczak E; Donoghoe M; Deshpande S; Morley C; King A; Doyle LW; Fleck BW; Davis PG; Halliday HL; Hague W; Cairns P; Darlow BA; Fielder AR; Gebski V; Marlow N; Simmer K; Tin W; Ghadge A; Williams C; Keech A; Wardle SP; Kecskes Z; Kluckow M; Gole G; Evans N; Malcolm G; Luig M; Wright I; Stack J; Tan K; Pritchard M; Gray PH; Morris S; Headley B; Dargaville P; Simes RJ; Brocklehurst P, 2016, 'Outcomes of two trials of oxygen-saturation targets in preterm infants', New England Journal of Medicine, 374, pp. 749 - 760, http://dx.doi.org/10.1056/NEJMoa1514212
    Journal articles | 2016
    Williams KH; Sullivan DR; Nicholson GC; George J; Jenkins AJ; Januszewski AS; Gebski VJ; Manning P; Tan YM; Donoghoe MW; Ehnholm C; Young S; O'Brien R; Buizen L; Twigg SM; Keech AC, 2016, 'Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study', Metabolism: Clinical and Experimental, 65, pp. 783 - 793, http://dx.doi.org/10.1016/j.metabol.2015.12.008
    Journal articles | 2015
    Donoghoe MW; Marschner IC, 2015, 'Flexible regression models for rate differences, risk differences and relative risks', International Journal of Biostatistics, 11, pp. 91 - 108, http://dx.doi.org/10.1515/ijb-2014-0044
    Journal articles | 2014
    Darlow BA; Marschner SL; Donoghoe M; Battin MR; Broadbent RS; Elder MJ; Hewson MP; Meyer MP; Ghadge A; Graham P; McNeill NJ; Kuschel CA; Tarnow-Mordi WO, 2014, 'Randomized controlled trial of oxygen saturation targets in very preterm infants: Two year outcomes', Journal of Pediatrics, 165, http://dx.doi.org/10.1016/j.jpeds.2014.01.017
    Journal articles | 2014
    Donoghoe MW; Marschner IC, 2014, 'Stable computational methods for additive binomial models with application to adjusted risk differences', Computational Statistics and Data Analysis, 80, pp. 184 - 196, http://dx.doi.org/10.1016/j.csda.2014.06.019
    Journal articles | 2013
    Blinman P; Gainford C; Donoghoe M; Martyn J; Blomfield P; Grant P; Kichenadasse G; Vaughan M; Brand A; Shannon C; Gebski V; Stockler M; Friedlander M, 2013, 'Feasibility, acceptability and preferences for intraperitoneal chemotherapy with paclitaxel and cisplatin after optimal debulking surgery for ovarian and related cancers: An ANZGOG study', Journal of Gynecologic Oncology, 24, pp. 359 - 366, http://dx.doi.org/10.3802/jgo.2013.24.4.359
    Journal articles | 2013
    Chan KH; O’Connell RL; Sullivan DR; Hoffmann LS; Rajamani K; Whiting M; Donoghoe MW; Vanhala M; Hamer A; Yu B; Stocker R; Ng MKC; Keech AC, 2013, 'Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study', Diabetologia, 56, pp. 724 - 736, http://dx.doi.org/10.1007/s00125-012-2818-4
    Journal articles | 2013
    Stenson BJ; Tarnow-Mordi WO; Darlow BA; Simes J; Juszczak E; Askie L; Battin M; Bowler U; Broadbent R; Cairns P; Davis PG; Deshpande S; Donoghoe M; Doyle L; Fleck BW; Ghadge A; Hague W; Halliday HL; Hewson M; King A; Kirby A; Marlow N; Meyer M; Morley C; Simmer K; Tin W; Wardle SP; Brocklehurst P, 2013, 'Oxygen saturation and outcomes in preterm infants', New England Journal of Medicine, 368, pp. 2094 - 2104, http://dx.doi.org/10.1056/NEJMoa1302298
    Journal articles | 2012
    Stanton K; Rao S; Assimes T; Wang B; McGee S; Harada R; Wilson A; Narasimhan B; Donoghoe M; Olin J; Cooke J; Ng M, 2012, 'Asymmetric Dimethylarginine (ADMA) Levels Correlate with Peripheral Vascular Disease Severity but not Coronary Artery Disease', Heart, Lung and Circulation, 21, pp. S11 - S11, http://dx.doi.org/10.1016/j.hlc.2012.05.034
    Journal articles | 2012
    Ting R; Keech A; Drury P; Donoghoe M; Hedley J; Jenkins AJ; Davis T; Lehto S; Celermajer DS; Simes J; Kushwin R; Stanton K; Suranyi MG, 2012, 'Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment', Diabetes Care, 35, pp. 218 - 225, http://dx.doi.org/10.2337/dc11-1109
    Journal articles | 2011
    Davis TME; Ting R; Best JD; Donoghoe MW; Drury PL; Sullivan DR; Jenkins AJ; O'Connell RL; Whiting MJ; Glasziou PP; Simes RJ; Kesäniemi YA; Gebski VJ; Scott RS; Keech AC, 2011, 'Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study', Diabetologia, 54, pp. 280 - 290, http://dx.doi.org/10.1007/s00125-010-1951-1
    Journal articles | 2011
    Donoghoe MW; Gebski V, 2011, 'Impact of the censoring distribution on time-to-event problems in the presence of competing risks', Trials, 12, http://dx.doi.org/10.1186/1745-6215-12-s1-a140
    Journal articles | 2011
    Joly F; Ray-Coquard I; Fabbro M; Donoghoe M; Boman K; Sugimoto A; Vaughan M; Reinthaller A; Vergote I; Ferrandina G; Dell'Anna T; Huober J; Pujade-Lauraine E, 2011, 'Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: Analysis from the GCIG CALYPSO relapsing ovarian cancer trial', Gynecologic Oncology, 122, pp. 226 - 232, http://dx.doi.org/10.1016/j.ygyno.2011.04.019
    Journal articles | 2011
    Scott R; Donoghoe M; Watts GF; O'Brien R; Pardy C; Taskinen MR; Davis TME; Colman PG; Manning P; Fulcher G; Keech AC, 2011, 'Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial', Cardiovascular Diabetology, 10, http://dx.doi.org/10.1186/1475-2840-10-102
    Journal articles | 2011
    Sullivan D; Forder P; Simes J; Whiting M; Kritharides L; Merrifield A; Donoghoe M; Colman PG; Graham N; Haapamäki H; Keech A, 2011, 'Associations between the use of metformin, sulphonylureas, or diet alone and cardiovascular outcomes in 6005 people with type 2 diabetes in the FIELD study', Diabetes Research and Clinical Practice, 94, pp. 284 - 290, http://dx.doi.org/10.1016/j.diabres.2011.07.028
    Journal articles | 2011
    Ting R; Davis T; Drury P; Donoghoe M; Rajamani K; Best J; Kesaniemi Y; Keech A, 2011, 'Cardiovascular Risk, Renal Status and Fenofibrate Safety in the FIELD Study', Heart, Lung and Circulation, 20, pp. S202 - S202, http://dx.doi.org/10.1016/j.hlc.2011.05.497
    Journal articles | 2010
    Rajamani K; Donoghoe M; Li L; Ting R-D; Colman P; Scott R; Laakso M; Keech A, 2010, 'FENOFIBRATE REDUCES PERIPHERAL NEUROPATHY IN TYPE 2 DIABETES: THE FENOFIBRATE INTERVENTION AND EVENT LOWERING IN DIABETES (FIELD) STUDY', ATHEROSCLEROSIS SUPPLEMENTS, 11, pp. 219 - 220, http://dx.doi.org/10.1016/S1567-5688(10)71046-1
    Journal articles | 2010
    Ting R-D; Davis TME; Drury PL; Donoghoe M; Rajamani K; Best JD; Kesaniemi YA; Keech AC, 2010, 'MS544 CARDIOVASCULAR AND RENAL SAFETY OF FENOFIBRATE IN THE FIELD STUDY', Atherosclerosis Supplements, 11, pp. 219 - 219, http://dx.doi.org/10.1016/s1567-5688(10)71044-8
    Journal articles | 2009
    Sullivan D; Donoghoe M; Simes J; George J; Keech T, 2009, 'Abstract: P496 LONG-TERM FENOFIBRATE USE IS ASSOCIATED WITH REDUCED PREVALENCE OF LIVER ENZYME ELEVATION IN THE FIELD STUDY', Atherosclerosis Supplements, 10, pp. e809 - e809, http://dx.doi.org/10.1016/s1567-5688(09)70791-3
  • Conference Abstracts | 2023
    Nagabushan S; Hamayun M; Fardell JE; Donoghoe M; Bland E; Bye A; Jacobson E; Manoharan N; Ziegler DS; McLoone JK; Johnson AM; Cohn RJ, 2023, 'LGG-11. COGNITIVE, ACADEMIC, AND QUALITY OF LIFE OUTCOMES IN SURVIVORS OF PEDIATRIC LOW-GRADE GLIOMA: CHALLENGING THE ‘BENIGN TUMOR’ PERCEPTION', in Neuro-Oncology, Oxford University Press (OUP), Vol. 25, pp. i57 - i58, http://dx.doi.org/10.1093/neuonc/noad073.221
    Conference Abstracts | 2022
    Body A; Wakefield C; Luong VTT; Donoghoe M; Fuentes Bolanos NA; Anazodo A; Ho C; Grech L; Ahern ES; Segelov E, 2022, 'Patient-reported toxicity and quality of life following Sars-CoV-2 vaccination in adults and children with cancer.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 40, pp. LBA12068 - LBA12068, http://dx.doi.org/10.1200/jco.2022.40.17_suppl.lba12068
    Conference Papers | 2022
    Body A; Wakefield C; Vi TTL; Donoghoe M; Bolanos NAF; Anazodo A; Ho C; Grech L; Ahern ES; Segelov E, 2022, 'Patient-reported toxicity and quality of life following Sars-CoV-2 vaccination in adults and children with cancer', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 03 June 2022 - 07 June 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000891791500044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2022
    McLoone J; Signorelli C; Wakefield CE; Donoghoe M; Johnston K; Bell R; Cohn RJ, 2022, 'The 'ENGAGE' program: Effective childhood cancer survivorship care', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 80 - 80, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000871956500081&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Preprints | 2022
    Spitzer H; Berry S; Donoghoe M; Pelkmans L; Theis F, 2022, Learning consistent subcellular landmarks to quantify changes in multiplexed protein maps, , http://dx.doi.org/10.1101/2022.05.07.490900
    Conference Abstracts | 2019
    Robertson E; Wakefield C; Cohn R; Robert B; Donoghoe M; Ziegler D; Fardell J; Mitchell R; O'Brien T, 2019, 'Delta: A Parent and Patient Decision Aid to Support Clinical Trial Decision-Making in Childhood Cancer', in PEDIATRIC BLOOD & CANCER, WILEY, Vol. 66, pp. S118 - S118, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488458001090&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2017
    Mitchell P; Siva S; Kok PS; O'Byrne K; Yeung A; Livingstone A; Donoghoe M; Yip S; Stockier MR, 2017, 'NIVORAD: A randomised phase 2 trial of nivolumab and stereotactic ablative body radiotherapy in advanced non-small cell lung cancer, progressing after first or second line chemotherapy.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at 53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 02 June 2017 - 07 June 2017, http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.9097
    Conference Posters | 2017
    Nowak A; Kok P-S; Livingstone A; Lesterhuis WJ; Yip S; Donoghoe M; Lam W-S; Stockler M, 2017, 'DREAM - A Phase 2 Trial of DuRvalumab with First Line chEmotherApy in Mesothelioma with a Safety Run In', Vol. 12, pp. S1086 - S1087, http://dx.doi.org/10.1016/j.jtho.2016.11.1518
    Conference Abstracts | 2015
    Barbour A; O'Rourke N; Chandrasegaram MD; Chua YJ; Kench J; Samra JS; Pavlakis N; Haghighi KS; Yip S; Fawcett J; Donoghoe M; Walker K; Burge ME; Gananadha S; Harris M; Aghmesheh M; Joubert WL; Gebski V; Simes J; Goldstein D, 2015, 'A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, IL, Chicago, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.4115
    Conference Papers | 2012
    Stanton KM; Rao SD; Assimes T; Wang B-Y; McGee S; Harada RK; Wilson A; Narasimhan B; Donoghoe M; Brown C; Keech A; Olin JW; Cooke JP; Ng MK, 2012, 'Plasma Asymmetric Dimethylarginine Levels Correlate with Peripheral Arterial Disease Severity but not Coronary Artery Disease', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208885006387&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2011
    Keech AC; Rajamani JK; Best JD; Hankey G; Donoghoe MW; Li L; Jenkins AJ; Ting R; Davis TME; Phillips P; Barter P, 2011, 'Predictors of peripheral neuropathy and effects of fenofibrate among 9,795 subjects with type 2 diabetes: the fenofibrate intervention and event lowering in diabetes (FIELD) study', in DIABETOLOGIA, SPRINGER, PORTUGAL, Lisbon, pp. S81 - S82, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), PORTUGAL, Lisbon, 12 September 2011 - 16 September 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307671300181&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2011
    Ting R; Davis TME; Jenkins AJ; Drury PL; Donoghoe MW; Rajamani JK; Kesaniemi AY; Best JD; Keech AC, 2011, 'Association of renal status and cardiovascular risk, and safety of fenofibrate in renal impairment in the FIELD study of 9,795 subjects with type 2 diabetes', in DIABETOLOGIA, SPRINGER, PORTUGAL, Lisbon, pp. S24 - S24, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), PORTUGAL, Lisbon, 12 September 2011 - 16 September 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307671300042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2011
    Ting R; Donoghoe M; Jenkins AJ; Hedley J; Rajamani K; Drury PL; Davis TME; Celermajer D; Simes RJ; Keech AC, 2011, 'Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes mellitus and renal impairment - the FIELD study', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, pp. 323 - 324, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208702703033&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2010
    Keech AC; Alicia J; Whiting M; Barter P; Sullivan DR; Donoghoe M; Januszewski A; Karschimkus C; Blankenberg S; Simes J; Scott R; Laakso M; Taskinen M-R; Best JD, 2010, 'Novel Cardiovascular Risk Factor Prediction of Cardiovascular Events in the (Type 2 Diabetes) FIELD Study and Effects of Fenofibrate', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208231602961&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2009
    Sullivan D; Donoghoe M; Simes J; George J; Keech T, 2009, 'LONG-TERM FENOFIBRATE USE IS ASSOCIATED WITH REDUCED PREVALENCE OF LIVER ENZYME ELEVATION IN THE FIELD STUDY', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000207957101492&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

  • 2022: President's Award for Leadership in Statistics, Statistical Society of Australia (Awarded to the 2020-2022 Branch Councils)
  • 2014: Award for Excellence in Postgraduate Research, Statistical Society of Australia
  • 2014: Certificate of Merit, Statistical Society of Australia (Outstanding presentation by a young statistician in the EJG Pitman Prize)
  • 2008: Norbert Quirk Prize IV, University of Sydney (Best essay in a mathematical subject)